Alkermes plc (ALKS) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Alkermes plc · Health Care · ref. ETF XLV · 66 calls · price $48.9
What the company does: Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
📈 Alkermes plc (ALKS) stock price
$48.9+69.0% over range
Aug 28, 25low $26.52 · high $55.22Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
82% recommend buying · 11 analysts
📊 JPI status : Alkermes plc has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 ALKS price target & analyst consensus — price $48.90
The price target · all analysts combined (11 targets)
Highest target · 3 firms of 11$65+32.9%
Median target · of 11 targets$61+24.7%
Lowest target · 1 firm of 11$38-22.3%
Current price$48.9
Where these 11 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
982%
$50 ↔ $65
Below
218%
$38 ↔ $48
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 11 ratings (last 6 months)
Strong Buy00%
Buy982%
Hold19%
Sell19%
Strong Sell00%
Go deeper on the analysts
🎯 ALKS price target all
All 12 calls, one by one, with our verdict on each firm.
→ See all 12 targets, analyst by analyst💡 The best analysts on ALKS most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in ALKS? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Alkermes plc? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on ALKS
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Needham ↗ | 100% | +70.3% | 3 |
| Evercore ISI Group ↗ | 100% | +22.4% | 2 |
| Cantor Fitzgerald ↗ | 83% | +10.0% | 6 |
| Piper Sandler ↗ | 83% | +6.6% | 6 |
| Morgan Stanley ↗ | 75% | +44.9% | 4 |
| JP Morgan ↗ | 67% | +57.7% | 3 |
| Baird ↗ | 67% | +8.2% | 3 |
| Goldman Sachs ↗ | 60% | +22.4% | 5 |
| Mizuho ↗ | 60% | +20.9% | 10 |
| Jefferies ↗ | 60% | +9.5% | 5 |
See the other 7 firms
| Deutsche Bank ↗ | 0% | -6.5% | 2 |
| B of A Securities ↗ | 25% | -30.5% | 4 |
| Barclays ↗ | 40% | -10.1% | 5 |
| Citigroup ↗ | 40% | +9.7% | 5 |
| Leerink Swann | 50% | +7.2% | 2 |
| UBS ↗ | 50% | +15.8% | 2 |
| Credit Suisse | 60% | +4.9% | 5 |
📊 What $1,000 invested in Alkermes plc would be worth › open the full page
In short — $1,000 invested in Alkermes plc 10 years ago would be worth $650 today, i.e. -4%/yr on average. Best year: 2021 (+17%), worst: 2018 (-46%). Price performance, excluding dividends.
If I'd invested $1,000 in Alkermes plc
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,794 | +79% |
| 3 years ago | $1,975 | +97% |
| 5 years ago | $2,586 | +159% |
Return by year (Alkermes plc)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +84% | $1,844 (+84%) |
| 2025 | -3% | $1,794 (+79%) |
| 2024 | +4% | $1,860 (+86%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Alkermes plc
Loading news…
📋 All analyst calls on ALKS
Filtered on — · ✕ show all
■ Neutral neutral · not a buy · 🎯$61
Price at call : $50.03 — gap to target +22%
Today : $48.9 — gap to target +25%
🎯 on ALKS : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
▲ Outperform · 🎯$58
Price at call : $48.34 — upside +20%
Today : $48.9 — upside +19%
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : Jul 29, 27
matures : Jul 29, 27
Piper Sandler ↗
Jul 28, 26
▲ Overweight · 🎯$65
Price at call : $48.34 — upside +34%
Today : $48.9 — upside +33%
🎯 on ALKS : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Jul 28, 27
matures : Jul 28, 27
▲ Buy · 🎯$63
Price at call : $52.85 — upside +19%
Today : $48.9 — upside +29%
🎯 on ALKS : no call matured yet · 📊 on Health : 44.8% · +6.7% (96 calls)
in progress (365j)
matures : Jul 20, 27
matures : Jul 20, 27
▲ Buy · 🎯$62
Price at call : $51.6 — upside +20%
Today : $48.9 — upside +27%
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Outperform · 🎯$65
Price at call : $54.58 — upside +19%
Today : $48.9 — upside +33%
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Jul 2, 27
matures : Jul 2, 27
Wells Fargo ↗
Jun 29, 26
▲ Overweight · 🎯$65
Price at call : $52.4 — upside +24%
Today : $48.9 — upside +33%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
B of A Securities ↗
Jun 29, 26
▼ Underperform · 🎯$38
Price at call : $52.53 — upside -28%
Today : $48.9 — upside -22%
🎯 on ALKS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Jun 29, 27
matures : Jun 29, 27
See the other 58 calls, newest to oldest
▲ Buy · 🎯$61
Price at call : $50.45 — upside +21%
Today : $48.9 — upside +25%
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jun 24, 27
matures : Jun 24, 27
▲ Buy · 🎯$50
Price at call : $48.07 — upside +4%
Today : $48.9 — upside +2%
🎯 on ALKS : no call matured yet · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Jun 22, 27
matures : Jun 22, 27
▲ Buy · 🎯$54
Price at call : $44.99 — upside +20%
Today : $48.9 — upside +10%
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Jun 18, 27
matures : Jun 18, 27
RBC Capital ↗
Jun 9, 26
▲ Outperform · 🎯$56
Price at call : $43.84 — upside +28%
Today : $48.9 — upside +15%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jun 9, 27
matures : Jun 9, 27
▲ Outperform · 🎯$48
Price at call : $38.91 — upside +23%
Today : $48.9 — upside -2%
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 37.8% · -2.8% (82 calls)
in progress (365j)
matures : May 13, 27
matures : May 13, 27
▲ Buy · 🎯$48
Price at call : $35.4 — upside +36%
Today : $48.9 — upside -2%
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
Wells Fargo ↗
May 6, 26
▲ Overweight · 🎯$44
Price at call : $35.4 — upside +24%
Today : $48.9 — upside -10%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
▲ Buy · 🎯$50
Price at call : $35.32 — upside +42%
Today : $48.9 — upside +2%
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : May 6, 27
matures : May 6, 27
B of A Securities ↗
Apr 9, 26
■ Neutral neutral · not a buy · 🎯$36
Price at call : $33.36 — gap to target +8%
Today : $48.9 — gap to target -26%
🎯 on ALKS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Apr 9, 27
matures : Apr 9, 27
Piper Sandler ↗
Mar 24, 26
▲ Overweight · 🎯$43
Price at call : $28.4 — upside +51%
Today : $48.9 — upside -12%
🎯 on ALKS : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Mar 24, 27
matures : Mar 24, 27
Wells Fargo ↗
Feb 26, 26
▲ Overweight · 🎯$43
Price at call : $30.1 — upside +43%
Today : $48.9 — upside -12%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
RBC Capital ↗
Feb 26, 26
▲ Outperform · 🎯$45
Price at call : $30.1 — upside +50%
Today : $48.9 — upside -8%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Feb 26, 27
matures : Feb 26, 27
Wolfe Research ↗
Feb 24, 26
▲ Outperform · 🎯$45
Price at call : $33.39 — upside +35%
Today : $48.9 — upside -8%
🎯 on ALKS : no call matured yet · 📊 overall : 35.2% · -2.7% (105 calls)
in progress (365j)
matures : Feb 24, 27
matures : Feb 24, 27
B of A Securities ↗
Feb 20, 26
■ Neutral neutral · not a buy · 🎯$34
Price at call : $31.91 — gap to target +7%
Today : $48.9 — gap to target -30%
🎯 on ALKS : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Feb 20, 27
matures : Feb 20, 27
Truist Securities ↗
Nov 17, 25
▲ Buy · 🎯$55
Price at call : $29.33 — upside +88%
Today : $48.9 — upside +12%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 17, 26
matures : Nov 17, 26
Wells Fargo ↗
Nov 13, 25
▲ Overweight · 🎯$37
Price at call : $29.04 — upside +27%
Today : $48.9 — upside -24%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
Deutsche Bank ↗
Nov 13, 25
▲ Buy · 🎯$45
Price at call : $31.01 — upside +45%
Today : $48.9 — upside -8%
🎯 on ALKS : 0% (1 call matured) · 📊 on Health : 32.7% · -7.6% (55 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
Truist Securities ↗
Nov 12, 25
▲ Buy · 🎯$50
Price at call : $31.01 — upside +61%
Today : $48.9 — upside +2%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
Truist Securities ↗
Nov 11, 25
▲ Buy · 🎯$50
Price at call : $33.81 — upside +48%
Today : $48.9 — upside +2%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 11, 26
matures : Nov 11, 26
Wells Fargo ↗
Oct 29, 25
▲ Overweight · 🎯$42
Price at call : $30.82 — upside +36%
Today : $48.9 — upside -14%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Buy · 🎯$44
Price at call : $31.45 — upside +40%
Today : $48.9 — upside -10%
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
in progress (365j)
matures : Oct 29, 26
matures : Oct 29, 26
▲ Outperform · 🎯$45
Price at call : $29.72 — upside +51%
Today : $48.9 — upside -8%
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
in progress (365j)
matures : Oct 27, 26
matures : Oct 27, 26
Piper Sandler ↗
Oct 23, 25
▲ Overweight · 🎯$45
Price at call : $29.8 — upside +51%
Today : $48.9 — upside -8%
🎯 on ALKS : no call matured yet · 📊 on Health : 45.8% · +6.9% (249 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
RBC Capital ↗
Oct 23, 25
▲ Outperform · 🎯$47
Price at call : $30.04 — upside +56%
Today : $48.9 — upside -4%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
RBC Capital ↗
Sep 26, 25
▲ Outperform · 🎯$44
Price at call : $27.89 — upside +58%
Today : $48.9 — upside -10%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Sep 26, 26
matures : Sep 26, 26
■ Neutral neutral · not a buy · 🎯$35
Price at call : $26.93 — gap to target +30%
Today : $48.9 — gap to target -28%
🎯 on ALKS : no call matured yet · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Sep 9, 26
matures : Sep 9, 26
HC Wainwright & Co. ↗
Sep 9, 25
■ Neutral neutral · not a buy · 🎯$46
Price at call : $27.85 — gap to target +65%
Today : $48.9 — gap to target -6%
🎯 on ALKS : no call matured yet · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Sep 9, 26
matures : Sep 9, 26
Wells Fargo ↗
Sep 3, 25
▲ Overweight · 🎯$44
Price at call : $30 — upside +47%
Today : $48.9 — upside -10%
🎯 on ALKS : no call matured yet · 📊 on Health : 37.5% · +1.0% (104 calls)
in progress (365j)
matures : Sep 3, 26
matures : Sep 3, 26
RBC Capital ↗
Jul 30, 25
■ Sector Perform neutral · not a buy · 🎯$42
Price at call : $26.49 — gap to target +59%
Today : $48.9 — gap to target -14%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Jul 30, 26
matures : Jul 30, 26
▲ Buy · 🎯$45
Price at call : $27 — upside +67%
Today : $48.9 — upside -8%
Expected +67% · Actual +79% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+79.0%
stock +79% · XLV +24%
matured Jul 29, 26
HC Wainwright & Co. ↗
Jul 21, 25
■ Neutral neutral · not a buy · 🎯$46
Price at call : $27.03 — gap to target +70%
Today : $48.9 — gap to target -6%
🎯 on ALKS : no call matured yet · 📊 on Health : 57.9% · +25.9% (321 calls)
in progress (365j)
matures : Jul 21, 26
matures : Jul 21, 26
▲ Buy · 🎯$45
Price at call : $26.66 — upside +69%
Today : $48.9 — upside -8%
Expected +69% · Actual +98% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+98.2%
stock +98% · XLV +22%
matured Jul 21, 26
Goldman Sachs ↗
Jul 15, 25
▲ Buy · 🎯$43
Price at call : $28.85 — upside +49%
Today : $48.9 — upside -12%
Expected +49% · Actual +80% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 50% (2 calls matureds) · 📊 on Health : 51% · +5.1% (102 calls)
+80.2%
stock +80% · XLV +19%
matured Jul 15, 26
▲ Buy · 🎯$42
Price at call : $29.77 — upside +41%
Today : $48.9 — upside -14%
Expected +41% · Actual +50% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
+49.5%
stock +50% · XLV +13%
matured Jun 17, 26
▲ Buy · 🎯$45
Price at call : $29.9 — upside +51%
Today : $48.9 — upside -8%
Expected +51% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 100% (3 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+33.6%
stock +34% · XLV +15%
matured May 28, 26
RBC Capital ↗
May 2, 25
■ Sector Perform neutral · not a buy · 🎯$40
Price at call : $31.4 — gap to target +27%
Today : $48.9 — gap to target -18%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : May 2, 26
matures : May 2, 26
▲ Outperform · 🎯$41
Price at call : $31.78 — upside +29%
Today : $48.9 — upside -16%
Expected +29% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 37.8% · -2.8% (82 calls)
+7.5%
stock +8% · XLV +4%
matured May 2, 26
■ Neutral neutral · not a buy · 🎯$33
Price at call : $28.77 — gap to target +15%
Today : $48.9 — gap to target -33%
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Apr 28, 26
matures : Apr 28, 26
Deutsche Bank ↗
Mar 27, 25
▲ Buy · 🎯$52
Price at call : $33.53 — upside +55%
Today : $48.9 — upside +6%
Expected +55% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 0% (1 call matured) · 📊 on Health : 32.7% · -7.6% (55 calls)
-12.3%
stock -12% · XLV -1%
matured Mar 27, 26
RBC Capital ↗
Mar 13, 25
■ Sector Perform neutral · not a buy · 🎯$40
Price at call : $33.62 — gap to target +19%
Today : $48.9 — gap to target -18%
🎯 on ALKS : no call matured yet · 📊 on Health : 30.7% · -10.7% (166 calls)
in progress (365j)
matures : Mar 13, 26
matures : Mar 13, 26
■ Neutral neutral · not a buy
🎯 on ALKS : 100% (1 call matured) · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Mar 5, 26
matures : Mar 5, 26
Goldman Sachs ↗
Feb 14, 25
▲ Buy · 🎯$32
Price at call : $35.89 — upside -11%
Today : $48.9 — upside -35%
Expected -11% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 50% (2 calls matureds) · 📊 on Health : 51% · +5.1% (102 calls)
-8.3%
stock -8% · XLV +9%
matured Feb 14, 26
▲ Outperform · 🎯$40
Price at call : $29.24 — upside +37%
Today : $48.9 — upside -18%
Expected +37% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+6.0%
stock +6% · XLV +4%
matured Nov 13, 25
Cantor Fitzgerald ↗
Oct 25, 24
▲ Overweight · 🎯$43
Price at call : $26.53 — upside +62%
Today : $48.9 — upside -12%
Expected +62% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+12.0%
stock +12% · XLV -2%
matured Oct 25, 25
Cantor Fitzgerald ↗
Oct 10, 24
▲ Overweight · 🎯$48
Price at call : $28.91 — upside +66%
Today : $48.9 — upside -2%
Expected +66% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+11.3%
stock +11% · XLV -8%
matured Oct 10, 25
Cantor Fitzgerald ↗
Sep 16, 24
▲ Overweight · 🎯$48
Price at call : $27.74 — upside +73%
Today : $48.9 — upside -2%
Expected +73% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+0.5%
stock +0% · XLV -12%
matured Sep 16, 25
Cantor Fitzgerald ↗
Jul 25, 24
▲ Overweight · 🎯$48
Price at call : $27.88 — upside +72%
Today : $48.9 — upside -2%
Expected +72% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
-6.2%
stock -6% · XLV -10%
matured Jul 25, 25
Cantor Fitzgerald ↗
May 23, 24
▲ Overweight · 🎯$48
Price at call : $24.02 — upside +100%
Today : $48.9 — upside -2%
Expected +100% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+24.5%
stock +24% · XLV -8%
matured May 23, 25
▲ Buy · 🎯$35
Price at call : $23.9 — upside +46%
Today : $48.9 — upside -28%
Expected +46% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+11.0%
stock +11% · XLV +21%
matured Oct 25, 24
▲ Buy · 🎯$36
Price at call : $28.34 — upside +27%
Today : $48.9 — upside -26%
Expected +27% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-12.9%
stock -13% · XLV +6%
matured Apr 26, 24
▲ Buy · 🎯$37
Price at call : $28.84 — upside +28%
Today : $48.9 — upside -24%
Expected +28% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-9.4%
stock -9% · XLV +6%
matured Apr 10, 24
▲ Buy · 🎯$36
Price at call : $24.5 — upside +47%
Today : $48.9 — upside -26%
Expected +47% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-0.5%
stock -0% · XLV -4%
matured Nov 22, 23
▲ Buy · 🎯$34
Price at call : $26.55 — upside +28%
Today : $48.9 — upside -30%
Expected +28% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+8.3%
stock +8% · XLV +2%
matured Jul 28, 23
Cantor Fitzgerald ↗
Jan 27, 22
▲ Overweight · 🎯$32
Price at call : $24.56 — upside +30%
Today : $48.9 — upside -35%
Expected +30% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 83% (6 calls matureds) · 📊 on Health : 50.6% · +13.8% (166 calls)
+18.2%
stock +18% · XLV +4%
matured Jan 27, 23
▲ Buy · 🎯$33
Price at call : $25.87 — upside +28%
Today : $48.9 — upside -33%
Expected +28% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
-2.7%
stock -3% · XLV -1%
matured Jul 29, 22
▲ Buy · 🎯$24
Price at call : $17.13 — upside +40%
Today : $48.9 — upside -51%
Expected +40% · Actual +77% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+76.9%
stock +77% · XLV +18%
matured Oct 15, 21
▲ Buy · 🎯$61
Price at call : $43.09 — upside +42%
Today : $48.9 — upside +25%
Expected +42% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on ALKS : 60% (10 calls matureds) · 📊 on Health : 26.4% · -9.4% (87 calls)
+47.4%
stock +47% · XLV +32%
matured Apr 10, 15
Frequently asked questions
Should I buy Alkermes plc stock?
This isn't buy advice. For Alkermes plc, the analyst consensus is "Buy", with an average price target of $61.00 (+25% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (3 calls tracked on Alkermes plc). We show the numbers — you decide.
Is it too late to buy Alkermes plc? How high can it go?
The most bullish analyst target on Alkermes plc is $65.00 (+33% above today's price); the average is $61.00. That's the upside they see. Check how reliable those analysts have actually been on Alkermes plc on our site before trusting it.
Is Alkermes plc still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Alkermes plc, the best hitting 100% over 3 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Alkermes plc? The case for and against
The arguments for and against, one by one, from the numbers: why invest in ALKS (and why hesitate).
What has Alkermes plc's past performance been?
Historical returns and a "how much if I had invested" calculator: ALKS performance & returns.
What is the best month to buy ALKS?
The 12 months ranked by the stock's past returns: best & worst month to buy ALKS.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX